Qepler | summits & conferences | Inhaled Drug Delivery Summit, Berlin, 23-24 May 2019
Event Location:
Berlin, Germany
Venue:
NH Collection Berlin Mitte am Checkpoint Charlie Leipziger Str. 106-111
Date:
23 May 2019 - 24 May 2019
Language:
English

Early Bird discounts:
Register early to save €500 for the Individual ticket, €600 per person for 2-3 Delegates, €700 per person for 4+ delegates from the same company until February 22nd.

Contact Person: Evgenia Makar
Contact Person: Evgenia Makar, Qepler s.r.o.
Contact Person: Denis Polikarpov
Contact Person: Denis Polikarpov, Qepler s.r.o.

Conference Overview

The recent years have witnessed major growth in the inhaled drugs market driven by rising prevalence of chronic pulmonary diseases, the evolution of inhaled therapies and technological advancements in device development. Challenges still remain to ensure safe and efficient respiratory drug delivery - including device and drug integration, particle engineering and formulation technologies, clinical studies and regulatory pathways. Our meeting facilitates hands-on experience sharing of successful development of inhaled drug products for enhanced patient care.

The featured talks on

  • Regulatory pathways in global respiratory market
  • Future needs for inhaled delivery systems
  • Safe and intuitive solutions for home care treatments
  • Human factor design and connecting technologies
  • Integrated development program for inhaled products
  • Next generation of molecules for pulmonary delivery
  • Preclinical inhalation drug development
  • Challenges of developing a generic inhalation product
  • Particle engineering for pulmonary drug delivery
  • Bioequivalence of inhalation products
  • Analytical tools for inhaled medicines
  • Manufacturing processes and selection of the right parameters

Meet our Speakers

PREVIOUS EVENT

Networking

Harshal Shah

Cambridge Consultants

chaired a panel discussion on the digitisation of clinical trials and next gen injectable devices, with speakers from Novartis, Roche, Janssen, Sanofi, SHL Group and Corvus Device.